Gary Vorsanger

Summary

Affiliation: Johnson and Johnson Pharmaceutical Research and Development
Country: USA

Publications

  1. doi request reprint Post hoc analysis of a randomized, double-blind, placebo-controlled efficacy and tolerability study of tramadol extended release for the treatment of osteoarthritis pain in geriatric patients
    Gary Vorsanger
    Ortho McNeil Janssen Scientific Affairs, LLC, Raritan, New Jersey 08869, USA
    Clin Ther 29:2520-35. 2007
  2. pmc Post hoc analyses of data from a 90-day clinical trial evaluating the tolerability and efficacy of tapentadol immediate release and oxycodone immediate release for the relief of moderate to severe pain in elderly and nonelderly patients
    Gary Vorsanger
    Janssen Scientific Affairs, LLC, Raritan, New Jersey, USA
    Pain Res Manag 16:245-51. 2011
  3. ncbi request reprint Evaluation of study discontinuations with tapentadol inmmediate release and oxycodone immediate release in patients with low back or osteoarthritis pain
    Gary Vorsanger
    Clinical Development, Ortho McNeil Janssen Scientific Affairs, LLC, Raritan, New Jersey, USA
    J Opioid Manag 6:169-79. 2010
  4. ncbi request reprint An observational study of health-related quality of life and pain outcomes in chronic low back pain patients treated with fentanyl transdermal system
    Mark R Kosinski
    QualityMetric Incorporated, Lincoln, RI, USA
    Curr Med Res Opin 21:849-62. 2005

Collaborators

Detail Information

Publications4

  1. doi request reprint Post hoc analysis of a randomized, double-blind, placebo-controlled efficacy and tolerability study of tramadol extended release for the treatment of osteoarthritis pain in geriatric patients
    Gary Vorsanger
    Ortho McNeil Janssen Scientific Affairs, LLC, Raritan, New Jersey 08869, USA
    Clin Ther 29:2520-35. 2007
    ....
  2. pmc Post hoc analyses of data from a 90-day clinical trial evaluating the tolerability and efficacy of tapentadol immediate release and oxycodone immediate release for the relief of moderate to severe pain in elderly and nonelderly patients
    Gary Vorsanger
    Janssen Scientific Affairs, LLC, Raritan, New Jersey, USA
    Pain Res Manag 16:245-51. 2011
    ..To evaluate the tolerability and efficacy of tapentadol immediate release (IR) and oxycodone IR for relief of moderate to severe pain in elderly and nonelderly patients...
  3. ncbi request reprint Evaluation of study discontinuations with tapentadol inmmediate release and oxycodone immediate release in patients with low back or osteoarthritis pain
    Gary Vorsanger
    Clinical Development, Ortho McNeil Janssen Scientific Affairs, LLC, Raritan, New Jersey, USA
    J Opioid Manag 6:169-79. 2010
    ..To examine discontinuations due to nausea and/or vomiting or constipation with tapentadol immediate release (IR) or oxycodone IR treatment...
  4. ncbi request reprint An observational study of health-related quality of life and pain outcomes in chronic low back pain patients treated with fentanyl transdermal system
    Mark R Kosinski
    QualityMetric Incorporated, Lincoln, RI, USA
    Curr Med Res Opin 21:849-62. 2005
    ..However, the broader effect of long-acting opioids on the patient's health-related quality of life (HRQoL) is less well known...